New clinical data from the DeCidE1 trial: Results on DPX-Survivac, low dose cyclophosphamide (CPA), and epacadostat (INCB024360) in subjects with advanced recurrent epithelial ovarian cancer

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 29; p. x31
Main Authors	Dorigo, O., Oza, A.M., Tanyi, J.L., Strauss, J., Pejovic, T., Ghamande, S., Ghatage, P., Villella, J., Fiset, S., MacDonald, L.D., Torrey, H., Weir, G.M., Hrytsenko, O., Stanford, M.M., Newton, R., Leopold, L., Rosu, G.N.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.12.2018
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdy487.018